Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2004. Start Trial.
Date Value
April 30, 2026 -0.7106
January 31, 2026 -0.7235
October 31, 2025 -0.7304
July 31, 2025 -0.7423
April 30, 2025 -0.7526
January 31, 2025 -0.7592
October 31, 2024 -0.8043
July 31, 2024 -0.8623
April 30, 2024 -0.5249
January 31, 2024 -0.5551
October 31, 2023 -0.5855
July 31, 2023 -0.6168
April 30, 2023 -0.6626
January 31, 2023 -0.6591
October 31, 2022 -0.6643
July 31, 2022 -0.6717
April 30, 2022 -0.7024
January 31, 2022 -0.7316
October 31, 2021 -0.7093
July 31, 2021 -0.7336
April 30, 2021 -0.7387
January 31, 2021 -0.7692
October 31, 2020 -0.7967
July 31, 2020 -0.7653
April 30, 2020 -0.7821
Date Value
January 31, 2020 -0.8096
October 31, 2019 -0.8068
July 31, 2019 -0.637
April 30, 2019 -0.6319
January 31, 2019 -0.6537
October 31, 2018 -0.6697
July 31, 2018 -0.6653
April 30, 2018 -0.692
January 31, 2018 -0.7228
October 31, 2017 -0.7673
July 31, 2017 -0.7724
April 30, 2017 -0.787
January 31, 2017 -0.8123
October 31, 2016 -0.816
July 31, 2016 -0.8156
April 30, 2016 -1.030
January 31, 2016 -1.341
October 31, 2015 -1.779
July 31, 2015 -0.9028
April 30, 2015 -0.8342
January 31, 2015 -0.8641
October 31, 2014 -0.9655
July 31, 2014 -0.9687
April 30, 2014 -0.8876
January 31, 2014 -1.155

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
MedX Health Corp. -0.8123
VentriPoint Diagnostics Ltd. -0.632
Theralase Technologies, Inc. 0.0217
Profound Medical Corp. 0.1482
VVT Med, Inc. -0.6369